Suzanne Nogami, MD
Obstetrics & Gynecology · Voorhees, NJNPI 1720304595
Payments from drug & device makers
Across 149 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$875
- Applied Medical Resources Corporation$406
- Exeltis, USA Inc.$279
- Therapeuticsmd, Inc.$251
- Bayer$120
- Coopersurgical, Inc.$93
- plus $985 from 29 others
What the payments were for
- Travel & lodging$31510%
- Food & beverage$2,64288%
- Education$532%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 54 | $875 |
| Applied Medical Resources Corporation | 2 | $406 |
| Exeltis, USA Inc. | 13 | $279 |
| Therapeuticsmd, Inc. | 13 | $251 |
| Bayer | 6 | $120 |
| Coopersurgical, Inc. | 5 | $93 |
| Lupin Inc. | 6 | $92 |
| Evofem Biosciences, Inc. | 5 | $82 |
| Mayne Pharma Commercial LLC | 4 | $77 |
| Conmed Corporation | 1 | $74 |
| Pfizer | 4 | $61 |
| Hologic Sales And Service, LLC | 2 | $59 |
| AMAG Pharmaceuticals, Inc. | 3 | $42 |
| Smith+Nephew | 3 | $41 |
| Myovant Sciences Inc. | 2 | $39 |
| Astellas Pharma US Inc | 2 | $37 |
| Sumitomo Pharma America, Inc. | 2 | $36 |
| Millicent US Inc | 2 | $31 |
| Amgen | 2 | $31 |
| Duchesnay USA Incorporated | 2 | $31 |
| Merck | 2 | $29 |
| Radius Health, Inc. | 1 | $25 |
| Exact Sciences | 1 | $22 |
| Urovant Sciences Inc | 1 | $19 |
| Renovia Inc | 1 | $18 |
| Roche Diagnostics Corporation | 1 | $18 |
| Medicem Inc. | 1 | $16 |
| Trevena, Inc. | 1 | $15 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Organon | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
| Mission Pharmacal Company | 1 | $12 |
| Mylan Pharmaceuticals Inc. | 1 | $12 |
| Novo Nordisk | 1 | $12 |
| Aspira Women's Health Inc | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,010 in reported general payments places this provider in the 85th percentile of 1,242 obstetrics & gynecology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,192 |
| Clobetasol Propionate | 12 | $706 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Voorhees
- Geoffrey BowersVoorhees$228K
- Paula JasionowskiVoorhees$193K
- Jeffrey LevineVoorhees$15K
- Richard DittrichVoorhees$9K
- Donna D EliaVoorhees$9K
- Jennifer AshtonEnglewood$1.5M
- Gregory HirschMorristown$1.3M
- Steven SussmanLawrenceville$623K
- Neha DeshpandePlainsboro$206K
- Justin ChuraSwedesboro$193K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.